Protalix BioTherapeutics, Inc. | Business Finance | Business Contracts

Description of Capital Stock (Filed With SEC on February 27, 2023)

Third Supplemental Indenture, dated as of August 24, 2021, by and among Protalix BioTherapeutics, Inc., the guarantors party hereto and The Bank of New York Mellon Trust Company,... (Filed With SEC on August 26, 2021)

Form of Exchange Agreement, dated as of August 12, 2021 among Protalix BioTherapeutics, Inc. and the Existing Holders (Filed With SEC on August 13, 2021)

Binding Term Sheet between Protalix Ltd. and Chiesi Farmaceutici S.p.A (Filed With SEC on May 14, 2021)

Underwriting Agreement, dated February 11, 2021, between the Company and BofA Securities, Inc (Filed With SEC on February 16, 2021)

Form of Stock Option Agreement (Executives) (Filed With SEC on August 10, 2020)

Form of Stock Option Agreement (Standard) (Filed With SEC on August 10, 2020)

Form of Warrant (Filed With SEC on March 12, 2020)

Form of Securities Purchase Agreement (Filed With SEC on March 12, 2020)

Description of Capital Stock (Filed With SEC on March 12, 2020)

Protalix BioTherapeutics, Inc. (68) | Business Finance (10)